CN1159026C - 治疗肿瘤的药物及其生产方法 - Google Patents

治疗肿瘤的药物及其生产方法 Download PDF

Info

Publication number
CN1159026C
CN1159026C CNB001293427A CN00129342A CN1159026C CN 1159026 C CN1159026 C CN 1159026C CN B001293427 A CNB001293427 A CN B001293427A CN 00129342 A CN00129342 A CN 00129342A CN 1159026 C CN1159026 C CN 1159026C
Authority
CN
China
Prior art keywords
medicine
medicines
radix
standby
mentioned
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB001293427A
Other languages
English (en)
Other versions
CN1355031A (zh
Inventor
赵清涛
赵录华
刘承
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANDONG LUYIN PHARMACEUTICAL CO Ltd
Wang Qi
Original Assignee
赵清涛
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4593419&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1159026(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 赵清涛 filed Critical 赵清涛
Priority to CNB001293427A priority Critical patent/CN1159026C/zh
Publication of CN1355031A publication Critical patent/CN1355031A/zh
Application granted granted Critical
Publication of CN1159026C publication Critical patent/CN1159026C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

本发明治疗肿瘤的药物,是由下述原料制成的药剂:人参、黄芪、白术、鸡内金、栝篓、半夏、厚朴、枳壳、郁金、丹参、全蝎、蜈蚣,是从祖国医药宝库中,筛选出益气健脾,理气化痰,活血行瘀,扶正固本,药膳同源的天然食用、药用的植物、动物药,按中医理论组方,以人参、黄芪为君药,以白术、鸡内金、栝篓、半夏为臣药,厚朴、积责、郁金、丹参为佐药,以全蝎、蜈蚣为使药,取其精华,使其发挥促进活血化瘀,又增强患者抗病能力,从而战胜癌症。

Description

治疗肿瘤的药物及其生产方法
本发明属于中药领域,特别涉及的是一种以中草药为原料制成的用治疗癌症的中成药,本发明还涉及该药物的生产方法。
癌症是严重危害人体健康的常见多发病,是人类死亡人数最多的病症之一。为了攻克癌症,世界各国都投入了大量的人力物力,也取得了不少可喜的成绩。专利文献中每年都有不少治疗肿瘤的中药,如93117306。X《抗癌口服液及其制备方法》、95109789。X《一种纯天然生物抗癌口服液及其制法》以及本人申请的专利97105686。2《安志化癌液及其生产方法》,均有明显的疗效。癌症的病因病机极为复杂,是因脏腑阴阳气血的失调,外来的致病因素与肌体内部的病理产物如痰结、湿聚、气滞、瘀血相搏结,目久不散而成;本病的发生,主要是在正虚的基础上脾胃受损,并与痰、瘀等邪相搏结所致,日久正虚邪实、虚实夹杂。总的治疗原则宜扶正与祛邪并举,即攻补兼施,以邪正兼顾。
本发明的目的是基于上述的分析,提供一种以中医治本的基础上益气健脾,理气化痰,活血行瘀,治疗癌症,尤其对胃癌术后化疗有明显疗效的治疗肿瘤的药物及其生产方法。
本发明的解决方案,是基于祖国医学对癌症的病因病机的分析,参考现代药理的研究成就,从祖国医药宝库中,筛选出益气健脾,理气化痰,活血行瘀,扶正固本,药膳同源的天然食用、药用的植物、动物药,按中医理论组方,提取精华,使其发挥促进活血化瘀,又增强患者抗病能力,从而战胜癌症。
本发明药物是由下列组分制成的:(用量为重量份)
人参11    黄芪16    白术6     鸡内金11    栝篓10    半夏6
厚朴6     枳壳6     郁金11    丹参8       全蝎3     蜈蚣6
一种上述治疗肿瘤的药物的生产方法,结合附图说明如下:
(1)、组分中各味药分别泡制好后,按重量份的要求,将上述泡制好的各味药称出备用;
(2)、取人参、丹参加入80%的乙醇提取3次,每次1小时,然后过滤,合并滤液,回收乙醇,在50℃使滤液相对密度至1.18-1.20;
(3)取白术、厚朴、郁金、积壳,加水浸湿,提取挥发油,5-6小时,水液滤过,滤液另存,药渣备用;
(4)将上述人参、丹参及白术、厚朴、郁金、积壳滤后的药渣与黄芪、栝篓、半夏合并在一起,加水煎煮三次,每次1小时,滤过,弃渣,合并滤液,在50℃的条件下浓缩至相对密度为1.18-1.22,再与上述人参、丹参乙醇提取浓缩液合并,在50℃继续浓缩至相对密度为1.30-1.36;
(5)在上述浓缩物中再加入鸡内金、全蝎、蜈蚣细粉混匀,80℃以下干燥,粉碎,备用;
(6)最后,将上述(3)中提取的挥发油与β-环状糊精按1∶10比例包结,冷藏,过滤,40℃以下干燥,粉碎过筛,与上述(5)中备用的干膏粉混合,加适量淀粉混匀,装1000粒胶囊,即得。取人参、丹参加入80%的乙醇提取3次,每次1小时,然后过滤,合并滤液,回收乙醇,在50℃使滤液相对密度至1.18-1.20;
上述生产方法中各味药的泡制方法说明如下:
人参:为生晒参润透,切薄片,干燥后备用;
黄芪:去杂质,大小分挡,洗净,润透,切厚片干燥后备用;
白术:除杂,洗净,润透,切厚片,干燥后备用;鸡内金:洗净后备用:
栝篓:去杂及果柄,洗净,压扁,切丝或块,晒干后备用;
半夏:去清半夏,大小分开,用8%的白矾溶液浸泡,至内无干心,口尝微有麻舌感,取出,洗净,切厚片后备用;
厚朴:除杂,刮去粗皮,洗净润透,切丝,干燥后备用;
积壳:除杂,洗净,润透,切薄片,干燥后筛去碎落的瓤核备用;
郁金:除杂,洗净,闷润至透,切薄片,干燥后备用;
丹参:除杂及残茎,洗净,闷润至透,切厚片,干燥后备用;
全蝎:除杂,洗净,干燥后备用;蜈蚣:除去竹片,剪成小段备用。
附图1为治疗肿瘤的药物的工艺流程图
附图说明:
由附图可看出,组成本发明治疗肿瘤的药物的12味原料加工工艺,可分三部分进行,一是将人参、丹参在80%的乙醇中提取3次后,过筛得到药渣备用;过滤得到的滤液回收乙醇后,得到流膏(1.18-1.20 50℃测),备用;
二是将白术、厚补、郁金、枳壳加水浸泡,一方面提取挥发油β-CD,包结、粉碎备用;另一方面过滤得到药渣和滤液,滤液备用;该药渣和人参、丹参提取后备用的药渣以及黄芪、栝萎、半夏合并在一起,用水提取三次,得到的药渣弃去,得到的滤液浓缩制成流膏(1.1 8-1.22 50℃测);该流膏与人参、丹参提取后的备用流膏合并,浓缩至相对密度为1.30-136(50℃),然后加入粉碎的鸡内金、蜈蚣、全蝎,混合,再与挥发油加淀粉混合,制成药粉,装胶囊得成品。
本发明治疗肿瘤的药物即为“参丹胶囊”,以人参、黄芪为君药,且用量较重,其中人参味甘性平,大补元气,补脾益肺之力甚佳,又能生津止渴,安神益智。该药对全身有良好的强壮作用,“能回阳气于垂绝,补气固脱”,为治虚劳内伤第一要药。黄芪甘温之品,具有益气生阳,固表止汗,又能利水消肿,托毒生肌,“补五脏诸虚不足”,“补元气,充腠理,治劳伤,长肌肉”,与人参配伍,相辅相成,疗效益增,以益气扶正,而治其本,增强肌体抗病能力。
白术、鸡内金、栝篓、半夏共为臣药。白术甘苦而温,系健脾益气药,能燥湿利水,长于治疗脾虚不运,水湿内停诸证。《医学启源》认为其有“除湿益燥,和中益气”,与君药人参、黄芪合用,加强两味益气健脾功效,以扶正培其本;鸡内金性味甘平,有健脾消食、消化石作用。本品消食之力较著,可用以多种原因的消化不良。《本草再新》记载:“健脾开胃,消食化疾,理气利湿”,说明鸡内金对局部肿块有消散之功;栝蒌甘寒,为清热化痰、宽胸化结之品。《本草新编》谓其“下气涤秽,消郁开胃”。《本草纲目》则说括蒌能“润肺燥,降火及涤痰结”;“利大肠,消痈肿疮毒”。该药的利大肠“即指润肠通便作用,以引邪下行,使之从大便排出;半夏辛散苦燥温通,功擅燥湿化痰,消痞散结。主治湿痰壅滞之咳喘痰及胸脘痞满诸证。《本草从新》言其“能走能散,和胃健脾,除湿化痰,发表开郁”以增加括蒌的化痰散结作用。
本方的佐药为厚朴、枳壳、郁金、丹参。厚朴苦辛温燥,功能行气消积,燥湿除满,对于食积气滞、湿阻胀满皆有良效。《药性论》曾谓本品“主疗积年冷气、宿食不消,除痰饮,去结水,破宿血,消化水谷,止痛。”枳壳苦酸微寒,具有理气宽胸、行气消积之功,为治气滞胸闷要药。《日华子本草》说其能“健脾开胃,调五脏,下气,止呕逆,消痰,治反胃、消食,破  结痃癖”。枳、朴二药合用,行气消积甚佳;除可缓解气滞、食积所致痞满胀痛等症外,另由于“气行则血行”,“气顺则痰消”,“气化湿亦化”,佐之君臣可补而不滞,而能理气化痰,还能加强栝篓、半夏散结消痰之力。郁金、丹参皆为寒性活血祛瘀止痛药物,为治疗瘕结块常用之品,其中郁金又能行气疏肝解郁,气行则血行,以加强活血之力,正如《本草备药》所说本品能“行气,解郁,泄血,破瘀”。丹参活血祛瘀,善治瘕积聚。以上四药合用共奏消食化痰、行气活血之功,针对痰结、湿聚、气滞、血瘀等病理产物,促其消散化结,重在祛邪。全蝎、蜈蚣蠕动之物,性善走窜,入络剔毒,能引诸药直达病所,具有引经作用,故而为方中的使药。
综观全方,主次分明,配伍严谨,分析其组成有以下优点:一是,选用人参、黄芪、白术类补气健脾药物以扶正。脾胃为后天之本,气血生化之源,三味配伍,相得益彰,致使正气充足,脾气熊旺,缓解改善体弱状态,以助抗邪,能增强肌体免疫力,有抗衰老、抗肿瘤作用;二是,全面兼顾,方中设有健脾胃,化积之鸡内金,化痰散结之栝萎、半夏,行气化湿之厚朴、枳壳,活血祛瘀之郁金、丹参,以及通络止痛,“以毒攻毒”之全蝎、蜈蚣,诸药合用则痰消、湿化、气行、血活。恰对胃癌的气虚痰结、血瘀等的病理产物,全方位地促其消散化解。总之,该方属消补兼施之剂,消中寓补,却邪而不伤正;补中有消,扶正又不碍邪,药味十二,君臣佐使相互协调,共奏益气健脾,理气化痰,活血行瘀之功能。

Claims (3)

1、一种治疗肿瘤的药物,其特征在于它是由下述重量配比的原料制成的药剂:
人参11    黄芪16    白术6     鸡内金11     栝篓10     半夏6
厚朴6     枳壳6     郁金11    丹参8        全蝎3      蜈蚣6
2、根据权利要求1所述的一种治疗肿瘤的药物的制备方法,该方法包括下述顺序的步骤:
(1)、组分中各味药分别泡制好后,按重量份的要求,将上述泡制好的各味药称出备用;
(2)、取人参、丹参加入80%的乙醇提取3次,每次1小时,然后过滤,合并滤液,回收乙醇,在50℃使滤液相对密度至1.18-1.20;
(3)取白术、厚朴、郁金、积壳,加水浸湿,提取挥发油,5-6小时,水液滤过,滤液另存,药渣备用;
(4)将上述人参、丹参及白术、厚朴、郁金、积壳滤后的药渣与黄芪、栝篓、半夏合并在一起,加水煎煮三次,每次1小时,滤过,弃渣,合并滤液,在50℃的条件下浓缩至相对密度为1.18-1.22,再与上述人参、丹参乙醇提取浓缩液合并,在50℃继续浓缩至相对密度为1.30-1.36;
(5)在上述浓缩物中再加入鸡内金、全蝎、蜈蚣细粉混匀,80℃以下干燥,粉碎,备用;
(6)最后,将上述(3)中提取的挥发油与β-环状糊精按1∶10比例包结,冷藏,过滤,40℃以下干燥,粉碎过筛,与上述(5)中备用的干膏粉混合,加适量淀粉混匀,装1000粒胶囊,即得。
3、根据权利要求2所述的治疗肿瘤的药物的制备方法,其特征在于:半夏的泡制方法为:取净半夏,大小分开,用8%白矾溶液浸泡,至内无干心,口尝微有麻舌感,取出,洗净,切厚片,干燥备用;厚朴的泡制方法为:去杂,刮去粗皮,洗净,润透,切丝,干燥备用。
CNB001293427A 2000-11-24 2000-11-24 治疗肿瘤的药物及其生产方法 Expired - Fee Related CN1159026C (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB001293427A CN1159026C (zh) 2000-11-24 2000-11-24 治疗肿瘤的药物及其生产方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB001293427A CN1159026C (zh) 2000-11-24 2000-11-24 治疗肿瘤的药物及其生产方法

Publications (2)

Publication Number Publication Date
CN1355031A CN1355031A (zh) 2002-06-26
CN1159026C true CN1159026C (zh) 2004-07-28

Family

ID=4593419

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB001293427A Expired - Fee Related CN1159026C (zh) 2000-11-24 2000-11-24 治疗肿瘤的药物及其生产方法

Country Status (1)

Country Link
CN (1) CN1159026C (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100336555C (zh) * 2003-09-01 2007-09-12 王砚光 一种抗肿瘤的参丹胶囊及其制备工艺
CN101637594B (zh) * 2009-09-07 2011-09-28 丁家武 一种益肾健脑保肝养心的中草药丸
CN113995808A (zh) * 2020-07-27 2022-02-01 潘小安 一种治疗癌症的药剂

Also Published As

Publication number Publication date
CN1355031A (zh) 2002-06-26

Similar Documents

Publication Publication Date Title
CN101940766B (zh) 一种治疗心肌梗塞的药物及其制备方法
CN103341064B (zh) 一种治疗癃闭的中药组合物
CN100389707C (zh) 一种保健药枕
CN103432390B (zh) 一种治疗冠心病的药物及其制备方法
CN102058870B (zh) 一种治疗风湿类风湿关节痛中风偏瘫的药物及其制备方法
CN104173773A (zh) 偏头痛祛风活血制剂及制备方法
CN105497816A (zh) 一种治疗动脉粥样硬化的中药制剂及其制备方法
CN104083728B (zh) 抗癌消瘤浓缩丸的加工方法
CN1159026C (zh) 治疗肿瘤的药物及其生产方法
CN104367926A (zh) 一种治疗五更泻的中药制剂及其制备方法
CN104353051A (zh) 一种治疗胃痛的中药制剂及其制备方法
CN105727089A (zh) 含艾叶的药物组合物用于制备治疗肠易激综合症药物中的用途
CN102600414B (zh) 一种治疗颈椎病的中药组合物
CN104623544A (zh) 中度脂肪肝健脾燥湿中药剂及制备方法
CN102614344A (zh) 用于治疗气血两虚型牙周炎的中药、制造方法及给药方式
CN100522197C (zh) 治疗高脂血症的中药制剂及其制备方法
CN1183938C (zh) 一种排毒、抗癌的中药制剂及其制备方法和应用
CN1210044C (zh) 一种治疗消化系肿瘤的中药及其制备方法
CN106692858A (zh) 一种治疗胎动不安的药物及其制备方法
CN105343794A (zh) 一种治疗神经衰弱的药物及其制备方法
CN104667040A (zh) 一种治疗心悸的中药组合物
CN104645002A (zh) 一种治疗肝肾阴虚的中药组合物
CN104225311A (zh) 神经衰弱补益心脾药剂及制法
CN104707031A (zh) 一种治疗老年性骨质疏松症的中药组合物及其制备方法
CN104173815B (zh) 治疗神经衰弱的中药组合物及制法

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20090206

Address after: No. 1, unit 7, Furong district, Chengguan District, Weicheng District, Shandong, Weifang, China 402

Patentee after: Sun Xiaoran

Address before: Building 11, unit 501, building 4, ten business road, three weft, Shandong, Ji'nan

Patentee before: Zhao Qingtao

ASS Succession or assignment of patent right

Owner name: SUN XIAORAN

Free format text: FORMER OWNER: ZHAO QINGTAO

Effective date: 20090206

C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Zhang Yajun

Document name: Notification of Passing Examination on Formalities

ASS Succession or assignment of patent right

Owner name: LIU DONG

Free format text: FORMER OWNER: SUN XIAORAN

Effective date: 20100122

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20100122

Address after: No. 1, unit 7, Furong district, Chengguan District, Weicheng District, Shandong, Weifang, China 402

Patentee after: Liu Dong

Address before: No. 1, unit 7, Furong district, Chengguan District, Weicheng District, Shandong, Weifang, China 402

Patentee before: Sun Xiaoran

PP01 Preservation of patent right

Effective date of registration: 20100210

Granted publication date: 20040728

PD01 Discharge of preservation of patent

Date of cancellation: 20100210

Granted publication date: 20040728

PP01 Preservation of patent right

Effective date of registration: 20100818

Granted publication date: 20040728

PD01 Discharge of preservation of patent

Date of cancellation: 20100818

Granted publication date: 20040728

ASS Succession or assignment of patent right

Owner name: WANG QI PAN ZHIZHONG DU BAOLONG

Owner name: SUN XIAORAN

Free format text: FORMER OWNER: LIU DONG

Effective date: 20110921

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20110921

Address after: 261041, No. 1, unit 7, Furong district, Chengguan District, Weicheng District, Shandong, Weifang 402, China

Co-patentee after: Wang Qi

Patentee after: Sun Xiaoran

Co-patentee after: Pan Zhizhong

Co-patentee after: Du Baolong

Address before: 261041, No. 1, unit 7, Furong district, Chengguan District, Weicheng District, Shandong, Weifang 402, China

Patentee before: Liu Dong

ASS Succession or assignment of patent right

Owner name: SHANDONG LUYIN PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: SUN XIAORAN

Effective date: 20150413

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 261041 WEIFANG, SHANDONG PROVINCE TO: 276017 LINYI, SHANDONG PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20150413

Address after: 276017 Torch Road 145, hi tech Industrial Development Zone, Shandong, Linyi

Patentee after: Shandong Luyin Pharmaceutical Co., Ltd.

Patentee after: Wang Qi

Patentee after: Pan Zhizhong

Patentee after: Du Baolong

Address before: 261041, No. 1, unit 7, Furong district, Chengguan District, Weicheng District, Shandong, Weifang 402, China

Patentee before: Sun Xiaoran

Patentee before: Wang Qi

Patentee before: Pan Zhizhong

Patentee before: Du Baolong

ASS Succession or assignment of patent right

Owner name: WANG QI

Free format text: FORMER OWNER: WANG QI PAN ZHIZHONG DU BAOLONG

Effective date: 20150512

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20150512

Address after: 276017 Torch Road 145, hi tech Industrial Development Zone, Shandong, Linyi

Patentee after: Shandong Luyin Pharmaceutical Co., Ltd.

Patentee after: Wang Qi

Address before: 276017 Torch Road 145, hi tech Industrial Development Zone, Shandong, Linyi

Patentee before: Shandong Luyin Pharmaceutical Co., Ltd.

Patentee before: Wang Qi

Patentee before: Pan Zhizhong

Patentee before: Du Baolong

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040728

Termination date: 20191124

CF01 Termination of patent right due to non-payment of annual fee